Phone app aims to keep diabetes patients on track with weekly injections
NCT ID NCT06478550
Summary
This study tested whether a smartphone app and a small device attached to an Ozempic pen could help people with type 2 diabetes continue their weekly injection treatment. About 300 participants who were already prescribed Ozempic were involved. The goal was to see if this digital support system made it easier for patients to stick with their medication over a 10-month period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
"Laiko" General Hospital of Athens
Goudi/Athens, 11527, Greece
-
General Hospital Of Thessaloniki Papageorgiou
Thessaloniki, Nea Efkarpia, 56429, Greece
-
General Hospital of Thessaloniki 'G. Gennimatas
Thessaloniki, 54635, Greece
-
Geniko Nosokomeio Peiraia Tzaneio
Piraeus, 18536, Greece
-
Univ Gen Hospital Larisa
Larissa, 41110, Greece
-
University Hospital of Athens ATTIKON
Athens, Attica, 12462, Greece
Conditions
Explore the condition pages connected to this study.